Total Clarity Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Total Clarity Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-143	Closed	-$7K	–	1017
2021 Q3	$7K	Buy	+143	New	+$7.46K	﹤0.01%	757

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Total Clarity Wealth Management's IDNA Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2021, closing a stake of 143 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in IDNA in Q3 2021 and held it in 1 quarter. The position peaked at $7K in Q3 2021. 103 funds tracked by Wall St. Rank hold IDNA as of Q4 2021.

Total Clarity Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2021 after selling out during the quarter.
Total Clarity Wealth Management sold 143 iShares Genomics Immunology and Healthcare ETF shares in Q4 2021, an estimated $7K.
Total Clarity Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2021 and held it in 1 quarter.
Total Clarity Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $7K in Q3 2021.
103 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.